Wittek Research Foundation for HCM retweeted
Join us Sun, Oct 25 at #HCM9 as we dive into trial endpoints, obesity, pregnancy, & workforce shifts — the questions shaping HCM care right now, not just in the lab, but at the bedside.
@steveommen, @noshreza, @carolinecoats, #JorgePlutzky & #AnnaRodonski dig in.

ALT Graphic titled "Elevating HCM Care" for International HCM Summit 9, promoting a session with five speakers: Steve Ommen, MD (HCM Clinical Trial Endpoints), Jorge Plutzky, MD (Obesity and HCM), Nosheen Reza, MD (HCM & Pregnancy), Caroline Coats, MD (Translating CPET to Patient Management), and Anna Rodonski, PA-C (Advanced Practitioners in HCM). Event details: Sunday, Oct 25, 2026, followed by a group panel. HCM Summit logo and hcmsummit.org in top right.
Wittek Research Foundation for HCM retweeted
This amazing anti-ICE song by @lynzylab on IG needs to go viral.
Super talented.
Wittek Research Foundation for HCM retweeted
Right Now, Not just Americans but whole world can see it, what Carl Sagan saw back in 1995.
Wittek Research Foundation for HCM retweeted
Flashback to 2020:
CA official: "If we ignore the science and put our head in the sand... we're not going to succeed together protecting Californians."
Trump: "It'll start getting cooler. You just watch."
"I wish science agreed with you."
Trump: "I don’t think science knows, actually."
Fascinating study, with clues towards hope for those at high risk for Alzheimer’s, and possible Alzheimer’s in general, as we learn more about the interactions of the different APOe genes statnews.com/2024/06/19/alzh… via @statnews
If you’d like the original paper with the 2024 AHA/ACC Guidelines for HCM MANAGEMENT, see link below.
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy #AHAJournals
ahajrnls.org/3UPk6Qd
Wittek Research Foundation for HCM retweeted
Here are the primary results of #aficamten in @NEJM
nejm.org/doi/full/10.1056/NE…
#HeartFailure2024 #CardioTwitter
The #SEQUOIA #HCM trial results are here - Placebo-controlled trial of #aficamten in #obstructive #HCM
3 presentations in 3 threads - follow along
This is the first presentation by @MartinMaronMD sharing the primary results
Follow along #CardioTwitter #HeartFailure2024
Wittek Research Foundation for HCM retweeted
Presented at #HeartFailure2024:
Among patients with symptomatic obstructive hypertrophic cardiomyopathy, treatment with aficamten led to a greater increase in peak oxygen consumption than placebo at 6 months. Full SEQUOIA-HCM phase 3 trial results: nej.md/3wmDzyl
Wittek Research Foundation for HCM retweeted
The 2024 #Myofilament Meeting in Madison, WI, has commenced with the Early Career Investigator Symposium, featuring extraordinary presentations. Over 200 participants worldwide have gathered to discuss and share the latest discoveries in #myofilament research.
Wittek Research Foundation for HCM retweeted
The American Heart Association guidelines for HCM treatment have just been updated for 2024. Cynthia Burstein Waldman @Cynaburst does a great job of breaking down the changes for you in this article from her blog HCMbeat: facebook.com/share/2ueWxZmkK…
The American Heart Association guidelines for HCM treatment have just been updated for 2024. Cynthia Burstein Waldman @Cynaburst does a great job of breaking down the changes for you in this article from her blog HCMbeat: facebook.com/share/2ueWxZmkK…
Wittek Research Foundation for HCM retweeted
Can the media please stop saying that “people don’t want Biden?” He literally won New Hampshire by 30+ points yesterday & got more votes than any presidential candidate in history in 2020. We do want President Biden & to suggest otherwise is deeply insulting & a lie.
Wittek Research Foundation for HCM retweeted
Reading this article should be required for all clinical geneticists and genetic counselors. So many insights from the perspective of a large family dealing w/ devastating autosomal dominant Frontotemporal dementia nytimes.com/2023/07/20/magaz…
Important early data from @MasriAhmadMD and @Cytokinetcs about #aficamten in non-obstructive HCM at #ACC
Here are the results of the #REDWOOD #HCM Cohort 4 trial. Follow along.
We enrolled 41 patients with non-obstructive HCM (nHCM) in an open label multi-center international phase II study
#CardioTwitter #ACC23
Exciting news from the LIVE-#HCM study at #ACC23. Kudos to @sday_hcm, Dr. Lampert@Yale and Michael J. Ackerman MD,PhD for bringing hope for a more normal and vigorous life to HCM patients !
via @NYTimes A fine tribute to Dr. Audrey Evans, whom I had the privilege of meeting once. At the age of 75, she still preferred to take the stairs rather than the elevator and I struggled to keep up with her! nytimes.com/2022/09/30/healt…
This important new study found a 10.9 percent gain in HCM genetic diagnoses that would have been missed in patients with suspected genetic cardiomyopathy or arrhythmia jamanetwork.com/journals/jam… genomeweb.com/molecular-diag…
Wittek Research Foundation for HCM retweeted
Bohemian rhapsody for postdocs:
Is this a real job?
Or more like a PhD?
Caught in short contracts
No chance of stability
Open your eyes
Look up to PIs and see
I'm just a postdoc
I get no sympathy
Because I'm easy come, easy go
Stress is high
Pay is low
Wittek Research Foundation for HCM retweeted
It’s time this loud and sometimes angry #womeninstemm threw in her 2 cents to the @NHMRC investigator grant gender equity discussion. First, it’s bloody brilliant the data has been analysed, modelled and some BIG options put forward. High five to everyone who helped do that /1



























